Triazole
- Sodium Bromide
- Potassium Fluoride (KF)
- HBr-Acetic acid
- 1-Acetyl-4-(4’- Hydroxyphenyl) Piperazine
- 2-Amino-5-Methyl Thiazol
- 2-Chloroethylamine Hydrochloride
- N,N BIS (2- Chloroethyl) Amine Hydrochloride
- 1-(4-Methoxy Phenyl) Piperazine
- 1-(2,3-Dichlorophenyl) Piperazine HCl
- 1-(2-Proponyl)-2- Benzimidazolidinone
- 1-(3-Chlorophenyl) Piperzine HCl
- P-ChloroBenzhydrylPiperazine
- Trans-4-(4- Floro- Phenyl)- N-Methyl-3-Hydroxy Methyl Piperidine (BisCarbinole)
- 4-Hydroxy Coumarin
- 4 4′ Di FluoroBenzophenone
- 4-Fluorophenylacetic Acid
- Triazole
- Sevelamar Carbonate: Poly(allylamine-co-N’N’diallyll,3-diamino-2-hydroxy propane)carbonate salt
- Zonisamide
- Albendazole
- Febendazole
- Mebendazole
- 5- (N-ethyl-N-2- hydroxyethylamino) -2–pentylamine (KSM of Hydroxychloroquine)
- 7-chloro- 4 – (5-(N-ethyl-N- 2-hydroxyethylamino)-2- pentyl) aminoquinolinediphosphate (Hydroxychloroquine)
- Dibenzo [b,f][1,4] Thiazepin- 11-11(10H)-one
- Meglumine
- Lornoxicam
- 6 (A)) Pyridine 3 – aldehyde (3-Nicotinaldehyde)
- 6-methyl-[pyridin-3- ylmethylideneamino]-2,5-dihydro-triazin-3-one
- 4-fluobenzonitrile
- 4-Fluoro nitrobenzene
- 2-fluoronitrobenzene
- N-ethyl- nitromethylpyrollidine
- 1(4-hydroxy phenyl)4-(4- nitrophenyl)piperazine
- Meta PhenoxyBenzaldehyde
- Para cresol
- 2,2’-Dinitro Biphenyl
- 2-Phenoxy Nitrobenzene
- Acetophenone derivatives
- Tallow alkyl nitrile
- Aldehyde derivatives
- Ritalinic Acid intermediates
- Atorvastatin intermediate
- 5-propylbenzo[d]-1,3- dioxole
- Potassium Fluoride (KF)
- 1-Acetyl-4-(4’- Hydroxyphenyl) Piperazine
- Dicyclopentadiene
- 2-phenyl propionaldehyde hydratropic aldehyde
- 5-Phenyl Thio-2-Nitro
- Potassium Fluoride (KF)
- HBr-Acetic acid
- Fluoro Benzyl Chloride
- 1-Acetyl-4-(4’- Hydroxyphenyl) Piperazine
- 2-Amino-5-Methyl Thiazol
- 2-Chloroethylamine Hydrochloride
- N,N BIS (2- Chloroethyl) Amine Hydrochloride
- 1-(4-Methoxy Phenyl) Piperazine
- Methyl 3-(4-methoxy-4- methylpentyl)-3- methyloxirane-2- carboxylate (MMGE)
- 1-(2,3-Dichlorophenyl) Piperazine HCl
- 1-(2-Proponyl)-2- Benzimidazolidinone
- Flupirtine maleate
- Etoricoxib
- Sesamol
Physical State | Powder |
Grade Standard | Technical Grade |
Usage | Industrial, Commerical |
Packaging Type | Export Worthy Packing of 25 Kilos or as per Our Customer Requirements |
Packaging Size | 25 KGS |
Minimum Order Quantity | 50 Kilogram |
Product Specification
Physical State | Powder |
Grade Standard | Technical Grade |
Usage | Industrial, Commerical |
Packaging Type | Export Worthy Packing of 25 Kilos or as per Our Customer Requirements |
Packaging Size | 25 KGS |
Minimum Order Quantity | 50 Kilogram |
Product Description
Triazoles are an important class of compounds used as core molecules for the synthesis of many pharmaceutical drugs. The objective of the present research was to investigate the influence of biofield treatment on physical, spectral and thermal properties of 1,2,4-triazole. The study was performed in two groups, control and treatment. The control group remained as untreated, and biofield treatment was given to treatment group. The control and treated 1,2,4-triazole were characterized by X-ray diffraction (XRD), Differential Scanning Calorimetry (DSC), Thermo Gravimetric analysis (TGA), Surface area analyzer, and Fourier transform infrared (FT-IR) spectroscopy. XRD analysis revealed a decrease in unit cell volume of treated 1,2,4-triazole (662.08 10-24 cm3) as compared to control sample (666.34 10-24 cm3). Similarly, a decrease in molecular weight of treated 1,2,4-triazole (69.78 g/mol) with respect to control (70.23 g/mol) was observed. Additionally, a substantial decrease in crystallite size (G) was observed in treated 1,2,4-triazole by 16.34% with respect to control. DSC analysis showed a slight increase in melting temperature of treated 1,2,4-triazole (124.22°C) as compared to control (123.76°C). Moreover, a significant increase in latent heat of fusion was noticed in treated 1,2,4-triazole by 21.16% as compared to control sample. TGA analysis showed a significant increase in maximum thermal decomposition temperature (Tmax) of treated 1,2,4-triazole (213.40°C) as compared to control (199.68°C). Surface area analysis using BET showed a substantial increase in surface area of the treated compound by 13.52% with respect to control. However, FT-IR analysis showed no structural changes in treated 1,2,4-triazole with respect to control. Overall, the result showed significant alteration of physical and thermal properties of the treated 1,2,4-triazole with respect to control.